Life
Gilead to buy cancer biotech Tubulis for more than $3 billion
Strategic angle: Gilead is acquiring the German biotech Tubulis, enhancing its oncology pipeline with a significant investment.
editorial-staff 4 days ago
#Gilead
3 articles tagged with "Gilead"
Life
Briefing: Pharmalittle: Trump Drug Pricing Flaw and Gilead Deal Insights
Strategic angle: Comments from a top Trump administration health official highlight significant issues in the president’s drug pricing plans.
editorial-staff 18 days ago
Money
Briefing: Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades
Strategic angle: Analysts are optimistic about Gilead Sciences' future growth, leading to recent upgrades.
editorial-staff 27 days ago